Objectives Cassia absus is a plant of the family fabaceae with Ayurvedic ethnomedical records. It is used in traditional medicine for the treatment of bronchitis, asthma, cough, conjunctivitis, leucoderma, renal and hepatic diseases, constipation, tumors, venereal ulcer, headache, hemorrhoids and wound healing. Preliminary in vitro and in vivo studies have provided valuable scientific evidence for its use. This review aims to summarize reported pharmacognosy, traditional uses, phytochemistry and pharmacological potential of C. absus while identifying potential areas of further research of plant. Key findings The review comprises literature pertaining to the evidence base therapeutic potential, pharmacognosy and phytochemistry of C. absus spanning from 1935 to 2016 using published articles in peer-reviewed journals, ethno botanical text books, and worldwide accepted scientific databases via electronic search (Elsevier, Google Scholar, PubMed, Scopus, Springer, Web of Science, Wiley online library). Kew Botanical Garden databases and the Plant List were used to authenticate the scientific names. Different pharmacological experiments in many in-vitro and in-vivo models have proved the potential of C. absus with antihypertensive, antifertility, antifungal, anti-inflammatory, anti-hyperglycemic, anti-glycation, antibacterial activity, a-amylase inhibitory activity, antioxidant and reducing activitity etc. chaksine, iso-chaksine, saturated and unsaturated fatty acids, chrysophanol, aloe-emodin and a wide range of chemical compounds have also been reported. Toxicity studies reveal the nontoxic nature of C. absus at a dose of 2000 mg/kg, however, plant possess reproductive toxicity and can be used as birth control or abortifacient. Summary Reported activities suggest that there is sufficient pharmacological potential for developing C. absus as a drug for hypertension, infections, diabetes and its complications. However, heterogeneity in study protocol and conflicting results mask the ability to replicate these studies. So, future studies should be replicated in line with best practices. More toxicological studies would aid the progress to clinical trial studies. Various ethno medical uses of C. absus have not been evaluated yet.
Introduction
Cassia absus is an erect annual plant, which belongs to family fabaceae. [1] Height of this plant is in the range of 1-2 ft. [2] The genus Chamaecrista also known as cassia belongs to subtribe Cassiinae. Cassiinae is divided into sections of unequal size (apoucouita, leguminosae, caliciopsis, grimaldia, chamaecrista, and absus). Cassia (Chamaecrista) is further divided into four subsections viz absus, adenophyllum, otophyllum, baseophyllum. [1] Its synonyms are Chaksu (Hindi), Chakusya, Aranyakullithaka (Sanskrit), Chimed (Gujarati), Ivala, Rankulith, Ranhulge (Marathi), Kann kutakin bij, Kadhulig (Kannada), Bankulthi, Banku kirti kalay (Bengali), Chanubala Vittulu (Telugu), Karum (Tamil), Jasmeejaz (English), and Shimbi Kul (Ayurveda). [3, 4] The leaves and seeds of C. absus are most commonly used for therapeutic purposes though the roots had also been studied. The leaves are acrid and bitter. In past, seeds were used to treat eye diseases. Due to its use for eye diseases, it is called chakshu, Chakusya (eye, in the Sanskrit language). [5] It is mainly distributed in India and Sri Lanka in wastelands up to 1500 m. It is present in all tropical regions across the world. [6] It is also found in the continents of Australia, Central America, and Africa. [5] It is traditionally used for the treatment of hypertension, irritable bowel syndrome, renal stones, conjunctivitis, trachoma, dacryocystitis, dysentery, bronchitis, asthma, cough, constipation, tumors, venereal ulcer, hemorrhoids, leucoderma, and hepatic diseases. [4, 5, [7] [8] [9] Recent research studies have shown that C. absus has antioxidant and antidiabetic properties. [4, 5, 10] Investigations of C. absus have focused on its biological activities, including its antihypertensive, antibacterial, antifertility, antifungal, anti-inflammatory, antiglycation, a-amylase inhibitory activity, trypsin inhibitory activity, antioxidant and reducing activities. [3] [4] [5] 10, 11] Reviewing the available literature, no review concerning C. absus is available. In this review, we intend to provide knowledge to researchers for rapid identification of chemical constituents and pharmacological activities of C. absus.
Traditional Uses of C. absus
Leaves of this plant were used traditionally for many diseases. The leaves are astringent and used in the bronchitis, asthma, cough, constipation, tumors, venereal ulcer, hemorrhoids, and yaw treatment. Leaves paste is used for wound healing and is externally applied on tumors. [5, [7] [8] [9] 12] Roots of C. absus (liquor form) are used to relieve constipation. [12] Cassia absus seeds used to cure different eye diseases like conjunctivitis, leucoderma, syphilitic ulcers, renal and hepatic diseases. Seed extract is used for ring worm infestations and skin diseases. [6, 13] Local application of seeds is traditionally used for skin diseases, leucoderma, and eye diseases. [12] It is a non-specific muscle relaxant and has curare-like activities. [10, 14] The seeds are used as cathartic. Paste of seeds is also used to treat various skin diseases and headache. [15] Seeds also have antihypertensive effect and are administered in powder form in a dose range of 1-2 g. [4, 16] Seeds powder is also used in hemorrhoids. [17] It also improves the blood as tonic. [18] The seeds of C. absus contain the flavonoids luteolin, apigenin, hydnocarpin, and isohydnocarpin. Paste of C. absus seed powder with honey is orally used for general type of cancer [19] and locally applied for wound healing and treatment of ringworm.
Decoction of C. absus seeds is traditionally used for irritable bowel syndrome and dysentery. [4] Chemical Constituents Table 1 summarizes the important phytoconstituents present in C. absus, and line drawings are illustrated in Figure 1 .
Leaves
The leaves contain chaksine, rutin, isochaksine, and quercetin. [7, 20, 21] 
Roots
Roots contain chrysophanol, aloe-emodin, chaksine, and isochaksine, and they are isolated from the roots. [9, 21] Seeds Seeds contain secondary metabolites including alkaloids, glycosides, saponins, flavonoids, tannins, and terpenoids. [1, 10] Steroids and cardiac glycosides are also present. [5] Seeds also contain amino acids, gums, resins. [13] Flavonoids luteolin and 5,7,4
galactopyranoside in seeds have antibacterial and antifungal effect. [20] Condensed tannins are also present in it. [1] Reducing sugars are not present in the seeds of C. absus. Alkaloids and saponin are present in large quantity while terpenoids and tannins are present in trace amounts. [28] Derivative of gentisic acids 5-O-b-D-glucopyranoside is also found in C. absus. [22] Two alkaloids, chaksine and isochaksine, were first isolated by Siddiqui and Ahmad from the seeds of the plant C. absus. Chaksine and isochaksine have molecular formula C 12 H 21 O 2 N 3 . [2] Roy and his coworkers showed that these bases have formula C 11 H 21 O 3 N 3.
[ 12] Fatty acids are present in large amount in seeds. 9-octadecenoic acid (oleic acid) was in highest amount followed by 9, 12-octadecadienoic acid; 22% of oil is methylated fatty acid that includes 15-methylheptadecanoic acid and 12-methyl tridecanoic acid. In addition, eicosanoic acid, linoleic acid, oleic acid are also present. [26] C. absus seeds contain fixed oils, saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids including arachidic acid, stearic acid, oleic acid, linoleic acid, palmitic acid, oleic acid, linolenic acid, and keto acid ketooctadeccis-15-enoiec acid. [27] Sterols present are campesterol, stigmasterol, and b-sterol. Β-sterol is the main component. Cholesterol, Δ 5 -avenasterol, and Δ 5-24 stigmastadienol are also present in small quantities. [1] Isolated constituents from seeds are isochaksine, chaksine, leutolin, linoleic acid, raffinose, b-sitosterol, and ketooctadec-cis-15-enoiec acid. [5] A new bioactive allelochemical with molecular formula C 34 H 42 O 20 and melting point of 235-236°C has been isolated from seeds of C. absus. Shinoda and Molish test proved that this compound is a flavonoid. Upon hydrolysis, it gives aglycone and glycone sugar namely D-xylose, L-rhamnose, and D-galactose. Structure of new compound was characterized as 5,7,4 [2, 13] roots, [9, 20, 21] leaves [21, 22] Anthraquinones Chrysophanol Roots [9, 21] Aloe-emodin Roots [9, 21] Flavone and flavonoids Quercetin Leaves [21] Rutin Leaves [21] Luteolin Seeds, [5, 20, 23, 24] Leaves [24] 5,7,4 0 -Trihydroxy-8,3
Seeds [23] Apigenin Seeds [1] Hydnocarpin Seeds [1] Isohydnocarpin Seeds [1] Carbohydrates Galactomananan Seeds [5, 25] Raffinose Fatty acids Linolenic acid Seeds [1, 5, 26, 27] Arachidic [22] Protein CAT1 Seeds [5, 11] Steroids and sterols Cholesterol Seeds [26] Triterpene alcohols b Amyrin Seeds [1] Cycloartenol 24 methylene -Cycloartenol Others Citric acid Leaves [7] Amide of citric acid
Another compound having m.p. of 326-28°C and molecular formula C 15 H 10 O 6 was also isolated and this isolated compound is luteolin. [23] Atomic absorption spectroscopy showed four essential trace metals, that is zinc, manganese, copper, and iron in C. absus in this order Fe ˃ Mn ˃ Zn ˃ Cu. It was found that iron is present in higher concentration. [29] Same order of concentration of these metals was studied by Khattak method. [30] Endosperm of fabaceae plants contains galactomannan, the reason for their mucilaginous nature. The amount of galactomannan in endosperm of C. absus is 55% of its weight. The seeds contain different glucose units, for example, D-mannose, D-galactose, and D-xylose. Most of the seed galactomannans have a main chain of 1?4 linked mannose units. The side chains are linked at C-6 and are composed of galactose and mannose. [25] Chaksine is an antibacterial against Streptococcus hemolyticus. It stimulates contraction of plain muscles like uterus, intestine, bladder, and muscles in blood vessels. It depresses the parasympathetic nerve endings of certain organs like intestine and bladder. It has local anesthetic effect intradermally and causes sustained fall in blood pressure in anesthetized rats. It has weak antiacetylcholine effect. [31] Chaksine has depressant effect on heart, nerve centers, and respiration. [12] Chaksine and b-sitosterol possess phytoprogesteronic effects. [26] C. absus seeds contain Figure 1 Structures of some compounds isolated from C. absus large quantity of linoleic acid and linolenic acid. These saturated and unsaturated fatty acids are helpful for many immunological reactions and control blood pressure. Linoleic acid has special effect on body composition; that is why it is very attractive for the scientific community. It reduces body fat mass and increases lean mass. [1] Pharmacological Activities
The traditional medicinal applications of C. absus have inspired many pharmacological investigations. Several extracts have been evaluated for their biological activities, especially antidiabetic, antibacterial, and antinicotinic activity. Table 2 lists the available pharmacological studies with detailed study methods and conditions.
Antihypertensive effect
In-vivo study showed that C. absus crude methanolic extract at 1-30 mg/ml lowers the blood pressure in a dose-dependent manner. The onset of action is few seconds and effect remains for longer duration than reference drug. Further, repeated injections of the same dose of the drug revealed tachyphylaxis. Reference drugs used in this study were atropine, ranitidine, chlorpheniramine, and propranolol.
Cassia absus did not lower acetylcholine-induced hypertension. Cassia absus does not act through the stimulation of muscarinic receptors of the blood vessels. Cassia absus neither affect the blood pressure-lowering effects of isoprenaline nor of histamine. In this way, it can be concluded that C. absus is not acting on beta-adrenergic and histaminic receptors. In anesthetized rats, C. absus eradicated the hypertension induced by bilateral carotid occlusion. This confirmed that C. absus was producing a fall in blood pressure by blocking the ganglia. Cassia absus has no effect on noradrenaline-induced hypertension, but showed obvious change or blockade of the hypertensive effect induced by nicotine. It may be concluded from this study that C. absus is not showing its effect by acting on a-adrenergic receptors but possesses an antinicotinic activity. [13] It may be possible that linoleic acid and linolenic acids present in C. absus are responsible for its antihypertensive action, and Aftab et al. study provides some validation to its traditional use for hypertension.
Aftab et al. study showed antinicotinic effect of C. absus. Antinicotinic property of C. absus proves its role in heart diseases and hypertension as nicotine alters the function of It has no effect on histaminic and betaadrenergic receptors. [13] Relaxant Methanolic seed extract 1-3 mg/ml (atria) In vitro CA produced relaxation of atria. It also has an antinicotinic activity. [13] 100-500 lg/ml (aorta, uterus and ileum)
In vitro CA produced relaxation of uterus, ileum and aorta so it exerts smooth muscles relaxant properties, both vascular and extravascular. [13] Antioxidant activity Petroleum ether extract IC 50 500 AE 0.05 In vitro DPPH scavenging activity at 500 ppm. But standard ascorbic acid showed at 14 ppm. [3] Chloroform extract IC 50 150 AE 0.20 In vitro DPPH scavenging activity at 150 ppm. But standard ascorbic acid showed at 14 ppm. [3] 500 lg/ml In vitro 52% inhibition of DPPH. [10] Ethyl acetate extract IC 50 12 AE 0.53 In vitro DPPH scavenging activity at 12 ppm. But standard ascorbic acid showed at 14 ppm. [3] 100 lg/ml In vitro 7.77% inhibition of DPPH. [5] 500 lg/ml In vitro 55% inhibition of DPPH. [10] Butanol extract IC 50 185 AE 0. 45 In vitro DPPH scavenging activity at 185 ppm. But standard ascorbic acid showed at 14 ppm. [3] Hydroalcoholic extract IC 50 66 AE 0.86 In vitro DPPH scavenging activity at 66 ppm. But standard ascorbic acid showed at 14 ppm. [3] 100 lg/ml In vitro 15.41% inhibition of DPPH. [5] Hexane fraction 100 lg/ml In vitro 6.8% inhibition of DPPH. [5] 500 lg/ml In vitro 75% inhibition of DPPH. [10] Aqueous extract IC 50 75 AE 0.92 In vitro DPPH scavenging activity at 75 ppm. But standard ascorbic acid showed at 14 ppm. [3] Chloroform extract IC 50 180 AE 1.00
In vitro
Reducing property at 180 ppm. But standard ascorbic acid showed at 11 ppm. [3] Ethyl acetate extract IC 50 9 AE 0.05
Reducing property at 9 ppm. But standard ascorbic acid showed at 11 ppm. [3] 100 lg/ml In vitro 0.4108 AE 0.45 absorbance at 700 nm while standard ascorbic acid showed 1.1526 AE 0.12 absorbance at 700 nm. [5] Butanol extract IC 50 198 AE 0.55
Reducing property at 198 ppm. But standard ascorbic acid showed at 11 ppm. [3] Hexane extract IC 50 84 AE 0.20
Reducing property at 84 ppm. But standard ascorbic acid showed at 11 ppm. [3] 100 lg/ml In vitro 0.1247 AE 0.33 absorbance at 700 nm while standard ascorbic acid showed 1.1526 AE 0.12 absorbance at 700 nm. [5] Aqueous extract IC 50 65 AE 0.48
Reducing property at 65 ppm. But standard ascorbic acid showed at 11 ppm. [3] Chloroform extract IC 50 130 AE 0.03 In vitro NO scavenging activity at 130 ppm. But standard ascorbic acid showed at 16 ppm. [3] Ethyl acetate extract IC 50 18 AE 0. 25 In vitro NO scavenging activity at 18 ppm. But standard ascorbic acid showed at 16 ppm. [3] Butanol extract IC 50 146 AE 0.52 In vitro NO scavenging activity at 146 ppm. But standard ascorbic acid showed at 16 ppm. [3] Hexane extract IC 50 65 AE 0.36 In vitro NO scavenging activity at 65 ppm. But standard ascorbic acid showed at 16 ppm. [3] Aqueous extract IC 50 95 AE 0.86 In vitro NO scavenging activity at 95 ppm. But standard ascorbic acid showed at 16 ppm. [3] Petroleum ether extract IC 50 580 AE 0.87 In vitro ABTS scavenging activity at 580 ppm. But standard gallic acid showed at 1.66 ppm. [3] Chloroform extract IC 50 110 AE 0. 25 In vitro ABTS scavenging activity at 110 ppm. But standard gallic acid showed at 1.66 ppm. [3] [3] Butanol extract IC 50 185 AE 0.87 In vitro ABTS scavenging activity at 185 ppm. But standard gallic acid showed at 1.66 ppm. [3] Hexane extract IC 50 65 AE 0. 45 In vitro ABTS scavenging activity at 65 ppm. But standard gallic acid showed at 1.66 ppm. [3] Aqueous extract IC 50 100 AE 0.69 In vitro ABTS scavenging activity at 100 ppm. But standard gallic acid showed at 1.66 ppm. [3] Anti-inflammatory Hexane fraction 400 lg/ml In vitro 66.55 AE 1.45% inhibition of albumin denaturation while standard drug diclofenac showed 29.86 AE 0.87% inhibition @ 400 lg/ml. [5] Ethyl acetate fraction 400 lg/ml In vitro 57.11 AE 1.08% inhibition of albumin denaturation while standard drug diclofenac showed 29.86 AE 0.87% inhibition @ 400 lg/ml.
[5]
In vitro 18.5 mm zone of inhibition against P. aeruginosa while streptomycin showed 22.2 mm @ 1000 ppm. [23] 15.5 mm zone of inhibition against S. aureus while streptomycin showed 22.5 mm @ 1000 ppm. [23] 11.5 mm zone of inhibition against B. coagulans while streptomycin showed 20.8 mm @ 1000 ppm. [23] Sterols from C. absus seed -In vitro 10 mm zone of inhibition against Listeria inocua.
[1]
8 mm zone of inhibition against Staphylococcus aureus.
12 mm zone of inhibition against Listeria ivanovii.
10 mm zone of inhibition against Escherichia coli.
12 mm zone of inhibition against Bacillus subtilis.
10 mm zone of inhibition against Bacillus cereus.
Triterpenic alcohols from C. absus seed -In vitro 8 mm zone of inhibition against L. inocua. [1] 10 mm zone of inhibition against L. ivanovii. [1] 9 mm zone of inhibition against E. coli. [1] 9 mm zone of inhibition against B. subtilis. [1] 10 mm zone of inhibition against B. cereus. [1] Methanolic seed extract 1000 lg In vitro 21 mm zone of inhibition against Micrococcus luteus.
[32]
Methanolic seed extract 1000 lg In vitro 13 mm zone of inhibition against Salmonella typhi.
Methanolic seed extract 1000 lg In vitro 14 mm zone of inhibition against S. aureus. [32] Methanolic seed extract 1000 lg In vitro 17 mm zone of inhibition against Klebsiella pneumoniae.
Citric acid 0.01 mol In vitro 20 mm zone of inhibition against Pseudomonas aeruginosa while Ampicillin showed 16 mm @ 10 mcg/disk. [7] 20 mm zone of inhibition against Nocardia calcarea while Ampicillin showed 20 mm @ 10 mcg/disk. [7] 19 mm zone of inhibition against B. subtilis while Ampicillin showed 17 mm @ 10 mcg/disk. [7] 18 mm zone of inhibition against Streptococcus pyogens while ampicillin showed 16 mm @ 10 mcg/ disk. [7] Amide of citric acid 0.01 mol In vitro 24 mm zone of inhibition against P. aeruginosa while ampicillin showed 16 mm @ 10 mcg/disk. [7] 22 mm zone of inhibition against Nocardia calcarea while ampicillin showed 20 mm @ 10 mcg/disk. [7] 23 mm zone of inhibition against B. subtilis while ampicillin showed 17 mm @ 10 mcg/disk. [7] [7] Crude leave soxhlet extract 0.01 mol In vitro 11 mm zone of inhibition against P. aeruginosa while ampicillin showed 16 mm @ 10 mcg/disk. [7] 14 mm zone of inhibition against Nocardia calcarea while ampicillin showed 20 mm @ 10 mcg/disk. [7] 13 mm zone of inhibition against B. subtilis while ampicillin showed 17 mm @ 10 mcg/disk. [7] 12 mm zone of inhibition against Streptococcus pyogens while ampicillin showed 16 mm @ 10 mcg/ disk. [7] Antifungal 5, 7, 4 0 -trihydroxy-8,
ppm
In vitro 17.5 mm zone of inhibition against Penicillium digitatum while griseofulvin showed 22.6 mm @ 1000 ppm. [23] 14.5 mm zone of inhibition against Fusarium oxysporum while griseofulvin showed 21.4 mm @ 1000 ppm [23] 10.5 mm zone of inhibition against Trichoderma viride while griseofulvin showed 22.5 mm @ 1000 ppm [23] Methanolic seed extract 1000 lg In vitro 18 mm zone of inhibition against Candida albicans.
Methanolic seed extract 1000 lg In vitro 18 mm zone of inhibition against Candida parapilosis.
Methanolic seed extract 1000 lg In vitro 21 mm zone of inhibition against Candida tropicalis.
Citric acid 0.01 mol In vitro 22 mm zone of inhibition against Trichosporon cutaneum while clotrimazole showed 22 mm @ 10 mcg/disk. [7] 21 mm zone of inhibition against Rhodotorula rubra while clotrimazole showed 18 mm @ 10 mcg/disk. [7] Amide of citric acid 0.01 mol In vitro 22 mm zone of inhibition against Trichosporon cutaneum while clotrimazole showed 22 mm @ 10 mcg/disk. [7] 22 mm zone of inhibition against Rhodotorula rubra while clotrimazole showed 18 mm @ 10 mcg/disk. [7] Crude leave soxhlet extract 0.01 mol In vitro 12 mm zone of inhibition against Trichosporon cutaneum while clotrimazole showed 22 mm @ 10 mcg/disk. [7] 11 mm zone of inhibition against Rhodotorula rubra while clotrimazole showed 18 mm @ 10 mcg/disk. [7] Antiglycation assay
Hexane and ethyl acetate fractions of seeds -
In vitro
Hexane fraction and ethyl acetate fraction showed 0.31 absorbance, negative control showed 4.2 absorbance while the standard amino guanidine showed 0.25 absorbance at 530 nm on day 21. [5] Methanol and butanol fractions of seeds 0.5 ml In vitro 16.2-44.5% inhibition in 1st week 18.5-55.17% inhibition in 2nd week 24.2-60.21% inhibition in 3rd week. [10] a -amylase inhibitory activity n-butanol seeds fraction 0.5 ml In vitro 72% inhibition of a-amylase while metformin showed 75% inhibition. n-hexane seeds fraction 0.5 ml In vitro 70% inhibition of a-amylase while metformin showed 75% inhibition. Chloroform seeds fraction 0.5 ml In vitro 68% inhibition of a-amylase while metformin showed 75% inhibition. Aqueous seeds fraction 0.5 mL In vitro 65 inhibition of a-amylase while metformin showed 75% inhibition. Ethyl acetate seeds fraction 0.5 ml In vitro 60% inhibition of a-amylase while metformin showed 75% inhibition.
vascular endothelium, initiates the adhesion cascade, and stimulates the vascular inflammatory events to induce hypertension. [33] However, in this study antinicotinic effect was only demonstrated by in-vitro local effect on guinea pig atria. [34] It does not confirm antinicotinic effect of C. absus and to validate this, further in-vivo and in-vitro experiments are required. [35] Moreover, antihypertensive effect of C. absus should also be evaluated in reflexive hypertension induced by local application of nicotine to the nasal mucosa. [36] Apart from methodology deficit, no statistical test was applied for comparison of different study groups.
Antioxidant activity
Reactive oxygen species represent a causal factor of the development and progression of several serious diseases, including cardiovascular disease, cancer, and neurodegenerative. The antioxidant effects of several medicinal plants, used in traditional medicine, are usually attributed to their polyphenolic compounds, flavonoids like luteolin, quercetin. [37] Six different types of extracts from C. absus namely petroleum ether extract, chloroform extract, ethyl acetate extract, hexane extract, butanol extract, and aqueous extract were evaluated for their antioxidant potential. Antioxidant and free radical scavenging activity was checked against free radicals DPPH, NO, and ABTS. Ethyl acetate extract was highly active against DPPH, NO, and ABTS and has IC 50 of 12 ppm, 18 ppm and 4 ppm while standard ascorbic acid showed IC 50 of 14 ppm, 16 ppm, and 1.66 ppm, respectively. IC 50 of other fractions ranges from 15 to 500 ppm against DPPH inhibition assay, 18-186 ppm against NO, and 65-58 against ABTS. [3] The analyses of reducing power and scavenging activities of DPPH radical showed that C. absus seed hexane fraction has marked inhibition of DPPH compared with butylated hydroxy toluene (positive control); 10-500 lg/ml of C. absus seed fractions were tested; however, dose of positive control was not mentioned. [10] Moreover, effect of only one dose was mentioned in study results and study lacks results of antioxidant effects of dose range mentioned and IC 50. This study lacks any statistical test for comparative effectiveness of different groups.
Seed extracts of C. absus were tested for the antioxidant activity through DPPH inhibition method. All the extracts exhibited low inhibitory power at 100 lg/ml compared ascorbic acid as a positive control. Cassia absus hydro- [3] Antitrypsin activity CAT1 from seeds In vitro Competitive-type inhibition with Ki = 5.6 9 10(À9) M. [11] Toxicity studies Ethyl acetate extract 300-2000 mg/kg In vivo Single dose showed no toxicity, convulsions, diarrhea, tremors, death, and change in behavior like selfmutilation, walking backward. [3] Ethyl acetate extract 300-2000 mg/kg In vivo Repeated dose showed no difference in weight, hemoglobin, hematocrit, red blood cells, white blood cells, other blood chemistry values, and histopathological analysis of organs as compared to control group. [3] Reproductive toxicity in female rats N-hexane fraction (seeds) 500 mg/kg b.wt. per day
In vivo
Fertility index 60 while control group showed 100 Ratio of fetus/rat in group 5.2 while control group has 8.6 Missed abortion 11, while control group has 3 Uterine weight, maternal body weight and levels of FSH, LH, and estradiol have insignificant change. [26] alcohol fraction exhibited 15.41% and hexane fraction exhibited 6.8% inhibition. Ethyl acetate and alcoholic fraction exhibited intermediate values of 7.77% and 8.43%, respectively. Moreover, C. absus has reducing power that can be defined as "ability to transform Fe (III) to Fe (II), confirmed by the formation of a blue colored complex." Reducing power was measured by spectrophotometry at 700 nm. The maximum reducing power of ethyl acetate extract may be due to presence of highest amount of flavonoid content in it. [5] Another study also reported the reducing power of ethyl acetate extract of C. absus with IC 50 9 ppm, whereas standard ascorbic acid has 11 ppm. [3] Nancy et al. [5] and Hussain et al. [10] represent contradictory results regarding antioxidant potential of C. absus seed fractions. The difference in results is marked in terms of percentage inhibition of DPPH as well as degree of efficacy of different fractions tested in both studies. Nancy et al. study showed 6.8% inhibition of DPPH by hexane fraction at 100 lg/ml, while Hussain et al. study showed 75% inhibition of DPPH by hexane fraction, but the dose was not mentioned clearly; 10-500 lg/ml dose range was tested, and there was no information on IC 50 . Lack of clarity in result description produces great confusion regarding antioxidant potential of C. absus seed extracts. However, another study described that C. absus seed extract has IC 50 of 1678 lg/ml. [1] Strong scientific methodologies are required before confirmatory decisions can be made on the antioxidant potential of C. absus. However, C. absus seeds contain high phenolic and flavonoid content including luteolin, quercetin, 3,5,7,4 0 -tetrahydroxy-2 0 ,5 0 -dimethoxy flavone, and others. [23] These isolated compounds could have antioxidant potential.
Antitrypsin activity
Seeds of C. absus possess a protein designated as CAT1 that has ability to inhibit bovine trypsin in a competitive manner. Trypsin inhibitory potential of CAT1 showed that it could be used as potential candidates for the development of the transgenic plant against the microbes and insect pests. [11] Antidiabetic activity a-amylase inhibitory activity a-amylase enzyme inhibitors are important in controlling diabetes mellitus. Cassia absus seed fractions inhibited aamylase enzyme concentration in concentration-dependent manner. Moreover, among tested fractions, n-butanol fraction was most effective against a -amylase enzyme. Amylase activity inhibition order was n-butanol > n-hexane > chloroform > aqueous > ethyl acetate.
Metformin was used as standard control while sodium phosphate buffer was sued as negative control. [10] Dose of standard antidiabetic drug was not mentioned, and statistical test was not applied for checking difference among different groups.
Antihyperglycemic effect in streptozotocininduced diabetic rats
Antihyperglycemic effect of ethyl acetate C. absus extract at a dosage of 250 and 500 mg/kg was observed after singledose administration and subacute treatment for 28 days in streptozotocin-induced diabetic rats. A highly significant (P < 0.001) decrease in plasma glucose level was observed after single-dose and subacute treatment of C. absus extract for 28 days as compared to diabetic control. However, the hypoglycemic effect of ethyl acetate C. absus extract at both tested dosages was somewhat less as compared to glibenclamide at a dose of 0.6 mg/kg. Anthraquinone group of metabolites is responsible for their antidiabetic effect and these are present in extract, so it can be assumed that anthraquinones are responsible for their antidiabetic potential. [3] The current study provides a preliminary data about antidiabetic potential of C. absus; however, mechanism of action of reducing plasma glucose level has not been explored. The study does not follow ARRIVE guidelines that are recommended for the conduction of animal experimentation.
Antiglycation activity
Glycation occurs between reducing sugars and it is nonenzymatic reaction, such as glucose and lipids, nucleic acids, and proteins. Glycation is totally different from glycosylation, which is an enzymatic reaction. [38] Glycation of proteins can cause many complications and degenerative diseases. Compounds having antiglycation potential can be used in management of complications of diabetes. Antiglycation assay is the degree of an extract to prevent or control the glycation of a standard protein in conditions mimicking in-vivo ones. Nitro blue tetrazolium (NBT) was used as a mediator in the antiglycation assay. When extract is not capable to prevent the glycation of proteins, glycated crops are formed. These glycated products have the ability to reduce NBT. Higher the decline of NBT by mixture, higher is the absorbance and higher is the quantity of glycated products present while lower the absorbance at 530 nm, higher the antiglycation activity. Cassia absus seed hexane fraction and ethyl acetate fraction have the highest antiglycation activity. The negative control showed the highest absorbance because glycation occurs due to absence of extract or standard control. The standard amino guanidine showed the higher powers of antiglycation as compared to extract in time-dependent manner.
In another study, C. absus seed fractions showed antiglycation activity in time-dependent manner. Methanol aqueous extract was most strong inhibitor; 16.2-44.5% fading in glycation was observed after first week of incubation. After 2 weeks of incubation, further reduction (18.5-55.17%) was detected and butanol portion was more potent in hindering glycation. Further 3 weeks of glycation study clogged BSA glycation by 24.2-60.21% and again n-butanol fraction had most prevailing obstruction potential. The standard amino guanidine showed more potent antiglycation potential in comparison with extract. [10] Both studies represent similar results about antiglycation potential of C. absus seed fractions. From these studies, it comes to know that methanol, n-butanol, n-hexane, and ethyl acetate fractions of C. absus seeds could have antiglycation property; moreover, results from both studies are clear, statistically analyzed, and matched so hopefully can be reproduced. Some polysaccharides, oligosaccharides, and polyphenols have antiglycation activity. These are present in C. absus seeds; [5] therefore, different fraction of C. absus seeds showed highest antiglycation activity.
Anti-inflammatory action
Traditionally, C. absus is used for its anti-inflammatory activity. [6, 13] Non-steroidal anti-inflammatory drugs (NSAIDS) reduce inflammation reduction through decrease in inflammatory cytokines such as IL-1b and TNFa and PGE2. [39] The anti-inflammatory potential of C. absus is checked through an assay that is used to check the factors that cause denaturation of proteins and cause inflammation. One of the main reasons of inflammation is denaturation of proteins. Purpose to study this activity was to find out ability of extract to stop inflammation. It was found that at 400 lg/ml hexane fraction showed highest inhibition. Anti-inflammatory activity of different fractions (CA-Hex, CA-EA, CA-AL, CA-HA) of extract at 400 lg/ml concentration was studied. Result showed that standard present low % inhibition as compared to various fractions of C. absus. CA-Hexane fraction showed highest inhibition at 400 lg/ml as compared to the standard and other extracts. Ethyl acetate fraction also gave better result. Order of % inhibition at 660 nm with 400 lg/ml concentrations was following:
Hexane fraction ˃ ethyl acetate fraction ˃ hydro alcoholic fraction ˃ standard ˃ alcoholic fraction CA-Hex, CA-EA, and CA-HA inhibition values were greater than standard. Hexane fraction is mostly used in eyedrops preparations due to higher inhibitory effect on denaturation of proteins. [5] This study does not confirm its anti-inflammatory potential as study results do not determine any effect on inflammatory mediators. Flavonoids including kaempferol, quercetin inhibits PGE2, and inflammatory cytokines [40] and are present in C. absus, so it could be an anti-inflammatory agent.
Antibacterial activity
Agar well/disk diffusion assay is the antibacterial method that estimates antibacterial potential of a sample qualitatively. [41] Broth microdilution assay is the antibacterial susceptibility testing method along with MIC determination. MIC 50 is the minimum concentration of antibacterial agent that can inhibit about 50% growth of bacteria in a microwell. [42] Sebei et al. [1] study demonstrated antibacterial activity of sterols and triterpenic alcohols against a number of bacterial strains through well diffusion assay. Sterols from C. absus seed oil showed the antibacterial activity against Listeria ivanovii, Listeria inocua, Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and Bacillus cereus, but major activity showed against L. ivanovii and B. subtilis. Triterpenic alcohols from C. absus seed oil also showed antibacterial activity against L. ivanovii, L. inocua, E. coli, B. subtilis, and B. cereus. Diameters of zone of inhibition range from 8 to 12 mm. [1] The data regarding tested dose, statistical test, and comparison with standard antibacterial drug were lacking. 5, 7, 4 0 -trihydroxy-8, 3
galactopyranoside, an isolated compound from seeds, has antibacterial activity, which was comparable to streptomycin (standard control). It was highly active against Pseudomonas aeruginosa (zone of inhibition; 18.5 mm) followed S. aureus (zone of inhibition; 15.5 mm) and then Bacillus coagulans (zone of inhibition; 11.5 mm) at 1000 ppm. [23] The antibacterial activity was measured by disk diffusion method, and quantitative estimation with MIC determination is required.
Cassia absus seed methanolic extract showed highest activity against M. luteusas compared to S. typhi, S. 1ureus, and K. pneumonia at 1000 lg. Order of activity at 1000 lg is M. luteus ˃ K. pneumonia ˃ S. aureus ˃ S. typhi. Cassia absus seed extract showed minimum inhibition within the range of 300-800 lg/ml in a dose-dependent manner. Methanolic extract showed minimum inhibition with MIC 50 of 300 lg/ml against M. luteus followed S. typhi with MIC 50 of 400 lg/ml, S. aureus with MIC 50 of 500 lg/ ml, and K. pneumonia with IC 50 of 600 lg/ml. [32] Linoleic acid inhibits the growth of S. aureus and other bacterial strains, [43] which might be possible for antibacterial potential of C. absus seed extract as it is present in large quantity in it. [1, 5, 27] Mathivanan et al. [32] demonstrated antibacterial activity of methanolic extract against different bacterial strains through agar well diffusion assay and broth microdilution assay and this is the first report on antibacterial activity of C. absus seed extracts both qualitatively and quantitatively. However, comparison with standard antibacterial drug was missing.
Crude leaves extract and two acidic components citric acid and amide of citric acid from leaves of C. absus showed antibacterial activity through cup plate agar method against some pathogenic bacteria namely B. subtilis, Streptococcus pyogenes, Nocardia calcarea, and P. aeruginosa that are responsible for various skin diseases. Ampicillin (10 mcg/disk) was used as standard control. It was also observed that the 0.01 mol of the citric acid was more effective as compared to 0.01 mol of the whole extract of the leaves. Leaves extract showed moderate antibacterial activity. Amide form (0.01 mol) of citric acid was found to be more active against all bacteria than citric acid and standard controls at same dose. [7] The study results provided high efficacy of C. absus leaves extracts and its isolated compounds as compared to standard control. Ampicillin is a broad-spectrum antibiotic; however, the source of standard antibiotics was not mentioned. Moreover, study results are based on single experiment instead of triplicate or duplicate; no statistical test was applied for analysis of results.
Antifungal activity
Isolated compound 5,7, 4 0 -trihydroxy-8, 3
galactopyranoside from seeds of C. absus also has antifungal activity. During this study, griseofulvin (1000 ppm) was used as standard. It showed 17.5 mm zone of inhibition against Penicillium digitatum, 14.5 mm against Fusarium oxysporum, and 10.5 mm against Trichoderma viride. [23] Crude leaves extract and two acidic components citric acid and amide of citric acid from leaves of C. absus showed antifungal activity through cup plate agar method against some fungal strains, namely Rhodotorula rubra and Trichosporon cutaneum. Clotrimazole (10 mcg/disk) was used as standard control. It was also observed that the 0.01 mol of the citric acid, and its amide was more effective as compared to 0.01 mol of the whole extract of the leaves and clotrimazole. [7] Cassia absus seed methanolic extract showed activity against Candida tropicalis, Candida albicans, and Candida parapilosis at 1000, 750, and 500 lg in a dose-dependent manner. Agar well diffusion assay was used for estimating antifungal activity. [32] The study lacks comparison of extract activity with standard antibiotic therapy.
Toxicology of C. absus
Ethyl acetate C. absus extract showed no toxicity, convulsions, diarrhea, tremors, death, and change in behavior like self-mutilation, walking backward, and so forth at a dose of 2000 mg/kg body weight (oral maximal tolerated dose). The repeated dose oral administration of ethyl acetate extract showed no difference in weight, hemoglobin, hematocrit, red blood cells, white blood cells, other blood chemistry values, and histopathological analysis of organs as compared to control group. Single and repeated dose studies showed non-toxic nature of C. absus in the dose range between 300 and 2000 mg/kg body weight in normal rats. [3] Reproductive toxicity Seeds of C. absus have been investigated for their safety profile in pregnant female rats. Female rats in treatment groups received C. absus n-hexane fraction at oral doses of 100, 200, and 500 mg/kg b.wt. per day, once per day on days one to five postcoitum. The control group received 0.2 ml of olive oil (vehicle). Fertility, hormone level, maternal index, and teratogenicity were evaluated. Female rat population of control group becomes pregnant. Fertility index of all groups receiving C. absus fraction decreased to 60. Total number of fetus and fetus rat ratio also decreases only in those rats who were receiving 200 and 500 mg/kg per day of the fraction. This study did not tell effect of C. absus on the implantation of blastocyte but shows that fertility index decreases in people; that is why it possesses the antifertility and abortifacient properties. The significant rise (50%) in the number of missed-aborted fetuses might be due to the direct reproductive toxicity effect of the C. absus on the fetuses, which revealed its toxicity in a dose-dependent manner. Docking studies reveal potential phytoprogesteronic effects of chaksine and b-sitosterol. Moreover, oral administration of C. absus n-hexane fraction at 500 mg/kg b.wt. per day elevated serum progesterone levels (27 AE 3.12) as compared to control (20.56 AE 2.59). [26] Discussion and Conclusion
The current review provides a comprehensive overview of the reported pharmacognosy, phytochemistry, and pharmacological activities of the plant C. absus. The plants' wide use in traditional medicine for various diseases has led to several scientific studies. Moreover, major findings of reported pharmacological activities are given in Table 2 .
Isochaksine, chaksine, leutolin, pyrogallol, linoleic acid, raffinose, b-sitosterol, and ketooctadec-cis-15-enoiec acid are the compounds isolated from C. absus. Linoleic acid may be responsible for antibacterial activity of C. absus as it inhibits the growth of S. aureus by inhibition of Enoyl-acyl carrier protein reductase (FabI) that is essential components of bacterial fatty acid synthesis pathway.. [43] Saponins affect catabolic enzymes in the bacteria that decrease the bacterial growth. [44] Many polyphenols, catechol, and pyrogallol derivatives exhibited maximum inhibitory activity against free radicals and H. pylori urease. [45] Luteolin, kaempferol, pyrogallol possess anti-inflammatory and carbonic anhydrase inhibiting activity. [46] Flavonoids like luteolin are responsible for the inhibition of free radicals and xanthine oxidase. [47] Some polysaccharides, oligosaccharides, and polyphenols have antiglycation activity. [5] The present review validates that C. absus extracts have pharmacological potential. Cassia absus has been investigated for its antihypertensive, antifungal, antiinflammatory, antiglycation, a-amylase inhibitory activity, antihyperglycemic activity, trypsin inhibitory activity, antibacterial activity, antioxidant, and reducing activities.
Phytochemical analysis of various parts of C. absus showed the presence of many important bioactive compounds. The high pharmacological potential reported in the articles reviewed here is may be due to these bioactive compounds. However, only a handful of studies evaluated the pharmacological potential of these isolated compounds as most articles described the activity of extracts.
During our review, we observed that some studies have conflicting results, which suggest that these studies may not provide reproducible data. Moreover, study protocols were improperly described and there was heterogeneity in study protocols. These factors could hinder the replication of experiments. Strong scientific methodologies are required before confirmatory decisions can be made on the potential of C. absus. In-vitro experiments reported many pharmacological activities of C. absus, and animal studies should be performed for these activities.
